UCB has become the latest focus of inquiries by Chinese officials in a growing clampdown on drug pricing and marketing practices in the country.
manbetx3.0
官方加大了对药品定价与营销手段的整治力度，比利时制药商优时比(UCB)成为最新调查目标。
您已阅读9%（190字），剩余91%（1873字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。